Hakan Kardes Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 16 hours ago
Hakan Kardes has an estimated net worth of at least $16.3 million*, as of April 2, 2025. They own 678,987 shares of ALHC stock. They have sold 292,995 shares of ALHC stock since 2021, for an estimated $3.9 million.
Hakan Kardes $ALHC SEC Form 4 Insider Trading
Hakan Kardes has filed a total of 17 insider trades in $ALHC since 2021. Their most recent trade was a sale of 7,225 shares, made on Mar 27, 2025. Their largest trade was a sale of 86,659 shares, made on Mar 06, 2025. We estimate that they now own 678,987 shares of $ALHC, worth an estimated $12.4 million.
Insider Trading at $ALHC
There have been a total of 263 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 51.5 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, John E Kao, and Dawn Christine Maroney. The most recent trade was a sale of 25,000 shares reported by CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer), made on Apr 01, 2025.
History of Insider Stock Trades by Hakan Kardes
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 7,225 | Mar 27, 2025 | March 28, 2025, 8:29 p.m. |
|
ALHC
|
Sale | 2,373 | Mar 19, 2025 | March 19, 2025, 9:53 p.m. |
|
ALHC
|
Sale | 25,000 | Mar 18, 2025 | March 19, 2025, 9:53 p.m. |
|
ALHC
|
Sale | 4,229 | Mar 19, 2025 | March 19, 2025, 9:53 p.m. |
|
ALHC
|
Sale | 4,787 | Mar 12, 2025 | March 13, 2025, 5:03 p.m. |
|
ALHC
|
Sale | 69 | Mar 12, 2025 | March 13, 2025, 5:03 p.m. |
|
ALHC
|
Sale | 86,659 | Mar 06, 2025 | March 6, 2025, 8:23 p.m. |
|
ALHC
|
Sale | 14,500 | Jan 24, 2025 | Jan. 24, 2025, 9:03 p.m. |
|
ALHC
|
Sale | 10,500 | Jan 21, 2025 | Jan. 23, 2025, 6:14 p.m. |
|
ALHC
|
Sale | 35,000 | Nov 27, 2024 | Nov. 29, 2024, 7:33 p.m. |
|
ALHC
|
Sale | 4,500 | Nov 01, 2024 | Nov. 5, 2024, 7:06 p.m. |
|
ALHC
|
Sale | 20,500 | Nov 04, 2024 | Nov. 5, 2024, 7:06 p.m. |
|
ALHC
|
Sale | 25,000 | Sep 12, 2024 | Sept. 13, 2024, 6:24 p.m. |
|
ALHC
|
Sale | 25,000 | Jul 16, 2024 | July 18, 2024, 4:41 p.m. |
|
ALHC
|
Sale | 4,363 | Mar 28, 2024 | March 29, 2024, 8 p.m. |
|
ALHC
|
Sale | 18,964 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
|
ALHC
|
Sale | 4,326 | Mar 15, 2024 | March 15, 2024, 8 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
John E Kao, Chief Executive Officer
-
Dawn Christine Maroney, President, Markets
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Hakan Kardes, Chief Experience Officer
-
Dawn Christine Maroney, President
-
Hyong Kim, Chief Medical Officer
-
Robert L. Scavo, Chief Information Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Richard A. Cross, SVP, General Counsel
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Donald Steven Furman, Chief Clinical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.